Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats
Authors:
- Jia HuJHJia Hu
- Jingyu ShenJSJingyu Shen
- Yonglin GaoYGYonglin Gao
- Yan LuYLYan Lu
- Tian WangTWTian Wang
- 1 August 2013
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 714 (1-3) , 83-88
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2010HQ049)
- Fundamental Study Funds of the Shandong Provincial Education Department (J11LF56)
This publication has 23 references indexed in Scilit:
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the diseaseBritish Journal of Pharmacology, 2011
- Simultaneous determination of monoamine and amino acid neurotransmitters in rat endbrain tissues by pre-column derivatization with high-performance liquid chromatographic fluorescence detection and mass spectrometric identificationTalanta, 2008
- Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant actionNeuroscience Letters, 2005
- Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line—derived neurotrophic factorJournal of Neurosurgery, 2005
- Adult neuron survival strategies — slamming on the brakesNature Reviews Neuroscience, 2004
- Neuroprotective Effects of Hydroxysafflor Yellow A:In Vivoandin VitroStudiesPlanta Medica, 2003
- Plasticity of Dopamine D4 Receptors in Rat Forebrain Temporal Association with Motor Hyperactivity Following Neonatal 6-Hydroxydopamine LesioningNeuropsychopharmacology, 2002
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996
- Neural transplantation — an experimental tool with clinical possibilitiesTrends in Neurosciences, 1991
- BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigraNature, 1991